Tag: including

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

  • Neftaly To contribute to the reduction of HIV/AIDS and TB related morbidity and mortality among cross border and mobile populations including refugees in IGAD member countries

    Neftaly To contribute to the reduction of HIV/AIDS and TB related morbidity and mortality among cross border and mobile populations including refugees in IGAD member countries

    Neftaly’s Regional Commitment: Reducing HIV/AIDS and TB-Related Morbidity and Mortality Among Mobile Populations in IGAD Member States

    Mobile and cross-border populations, including refugees and migrant workers, face unique vulnerabilities and limited access to essential health services—placing them at greater risk for HIV/AIDS and tuberculosis (TB). In line with regional health priorities, Neftaly is committed to reducing the burden of HIV/AIDS and TB-related morbidity and mortality among these underserved groups across IGAD member countries.

    Our Mission:

    To ensure that no one is left behind in the fight against HIV and TB by supporting the development of inclusive, accessible, and cross-border health strategies that serve the needs of mobile and displaced populations in the Intergovernmental Authority on Development (IGAD) region.

    Strategic Objectives:

    • Strengthen Cross-Border Health Systems: Support the development of coordinated cross-border health services to ensure continuity of care for individuals moving between countries.
    • Increase Access to Testing and Treatment: Facilitate access to HIV and TB testing, treatment, and prevention services for refugees, asylum seekers, truck drivers, seasonal laborers, and nomadic populations.
    • Community Outreach and Awareness: Deploy culturally sensitive, multilingual outreach campaigns to raise awareness, reduce stigma, and encourage early diagnosis and treatment adherence.
    • Data Sharing and Surveillance: Promote regional collaboration on surveillance systems, data sharing, and health information management to track disease trends and improve cross-border response.
    • Capacity Building and Integration: Train health workers, border officials, and community volunteers to identify, refer, and support individuals at risk, and integrate services into existing national and regional health systems.
    • Policy Advocacy: Engage with IGAD, national governments, and partners to strengthen regional policies that uphold the right to health for mobile populations and refugees.

    Our Impact:

    By working across borders and sectors, Neftaly aims to:

    • Reduce new infections and deaths from HIV/AIDS and TB
    • Improve treatment continuity for mobile and displaced individuals
    • Enhance health system responsiveness across IGAD countries
    • Foster regional solidarity in addressing public health threats
  • Neftaly To contribute to the reduction of new HIV infections and TB incidence among cross border and mobile populations including refugees in IGAD member countries

    Neftaly To contribute to the reduction of new HIV infections and TB incidence among cross border and mobile populations including refugees in IGAD member countries

    Neftaly’s Regional Commitment: Reducing New HIV Infections and TB Incidence Among Cross-Border and Mobile Populations in IGAD Member Countries

    Cross-border and mobile populations—including refugees, migrant workers, pastoralists, and transport workers—face heightened vulnerability to HIV and tuberculosis (TB) due to limited access to health services, social exclusion, and mobility-related disruptions in care. Recognizing these unique challenges, Neftaly is committed to contributing to the reduction of new HIV infections and TB incidence across IGAD member states.

    Our Mission:

    To strengthen regional, national, and local capacities to provide inclusive, accessible, and continuous HIV and TB prevention, diagnosis, and treatment services to mobile and displaced populations across the Intergovernmental Authority on Development (IGAD) region.

    Strategic Focus Areas:

    • Cross-Border Health Service Integration: Support the harmonization and coordination of HIV and TB services across IGAD borders to ensure continuity of care for mobile populations.
    • Community Engagement and Health Education: Implement culturally appropriate awareness campaigns that target high-risk groups with accurate information about HIV and TB prevention, testing, and treatment adherence.
    • Access to Testing and Treatment: Expand outreach and mobile health services to provide HIV testing, TB screening, antiretroviral therapy (ART), and TB treatment in refugee settlements, border towns, and high-transit areas.
    • Health Workforce Capacity Building: Train border health officials, community health workers, and local partners to improve early detection, treatment linkage, and follow-up for HIV and TB cases.
    • Surveillance and Data Sharing: Strengthen regional disease surveillance systems and promote cross-border data sharing to identify hotspots, track treatment outcomes, and respond rapidly to emerging trends.
    • Policy Advocacy and Collaboration: Work with IGAD, national governments, and other stakeholders to develop and implement policies that protect the health rights of mobile and displaced populations.

    Our Impact:

    By delivering targeted, cross-border interventions, Neftaly aims to:

    • Reduce the number of new HIV infections among mobile and cross-border populations
    • Lower TB incidence and support successful treatment outcomes
    • Improve access to continuous and equitable healthcare
    • Strengthen regional solidarity and public health collaboration across IGAD countries

    Neftaly stands with IGAD member countries in creating a regional health framework that leaves no one behind—regardless of where they live, move, or seek refuge.

  • Neftaly To control malaria in pregnancy including its effects on low birth weight through case management and distribution of ITNs and intermittent preventive treatment in targeted areas.

    Neftaly To control malaria in pregnancy including its effects on low birth weight through case management and distribution of ITNs and intermittent preventive treatment in targeted areas.

    Neftaly’s Initiative to Control Malaria in Pregnancy and Its Impact on Low Birth Weight

    Malaria during pregnancy poses serious health risks to both the mother and the unborn child, including increased chances of low birth weight, maternal anemia, and infant mortality. Addressing malaria in pregnancy is critical to improving maternal and newborn health outcomes.

    Neftaly is committed to controlling malaria in pregnancy through a comprehensive approach that includes:

    • Effective Case Management: Ensuring timely diagnosis and appropriate treatment of malaria in pregnant women to prevent complications and adverse outcomes.
    • Distribution of Insecticide-Treated Nets (ITNs): Providing pregnant women in targeted areas with ITNs to protect them from mosquito bites and reduce malaria transmission.
    • Intermittent Preventive Treatment in Pregnancy (IPTp): Supporting the delivery of IPTp with recommended antimalarial drugs during antenatal visits to prevent malaria infection and its harmful effects.
    • Community Awareness and Education: Raising awareness among pregnant women and communities about the risks of malaria and the importance of prevention and early treatment.
    • Strengthening Health Systems: Collaborating with healthcare providers to improve antenatal care services and ensure consistent availability of malaria prevention and treatment tools.

    Through these targeted interventions, Neftaly aims to reduce the incidence of malaria in pregnancy, thereby lowering rates of low birth weight and improving the health and survival of mothers and their babies.

  • Neftaly To control malaria in pregnancy including its effects on low birth weight through case management, distribution and replacement of LLINs to all pregnant women in LLIN targeted areas and, IPTp in stratum 5 and 6

    Neftaly To control malaria in pregnancy including its effects on low birth weight through case management, distribution and replacement of LLINs to all pregnant women in LLIN targeted areas and, IPTp in stratum 5 and 6

    Neftaly’s Commitment to Controlling Malaria in Pregnancy and Reducing Low Birth Weight

    Malaria in pregnancy remains a major public health concern, significantly contributing to adverse outcomes such as low birth weight, maternal anemia, and increased infant mortality. Effective interventions are essential to protect mothers and their babies, especially in high-risk areas.

    Neftaly is dedicated to controlling malaria in pregnancy through a comprehensive strategy that includes:

    • Case Management: Providing timely diagnosis and effective treatment for pregnant women affected by malaria to prevent complications and improve maternal and fetal health outcomes.
    • Distribution and Replacement of Long-Lasting Insecticidal Nets (LLINs): Ensuring all pregnant women in LLIN-targeted areas receive LLINs, with regular replacement campaigns to maintain effective protection against mosquito bites throughout pregnancy.
    • Intermittent Preventive Treatment in Pregnancy (IPTp): Delivering IPTp with recommended antimalarial drugs specifically in stratum 5 and 6 regions, where malaria transmission risk is highest, to prevent infection and its associated risks.
    • Community Engagement and Education: Raising awareness about the importance of using LLINs and adhering to IPTp schedules to protect both mother and child.
    • Strengthening Antenatal Care Services: Collaborating with healthcare providers to integrate malaria prevention and treatment into routine antenatal care, ensuring consistent access to these life-saving interventions.

    By focusing on these targeted interventions in high-risk areas, Neftaly aims to reduce the burden of malaria in pregnancy and its detrimental effects on newborn health, including lowering the incidence of low birth weight.